Group 1:new oncolytic vaccine
Sponsors
The First People's Hospital of Changde City
Conditions
Cervical Cancer
Early Phase 1
A prospective, open and controlled clinical study of traditional Chinese medicine (Astragalus / Panax notoginseng) combined with a new oncolytic vaccine in the treatment of Recurrent or Metastatic Cervical Cancer
RecruitingChiCTR2000037806
Start: 2020-09-01Updated: 2020-11-09
A prospective, open and controlled clinical study of traditional Chinese medicine (Astragalus / Panax notoginseng) combined with a new oncolytic vaccine in the treatment of Recurrent or Metastatic Cervical Cancer
RecruitingITMCTR2000003879
Start: 2020-09-01Updated: 2023-02-20